Global Benzodiazepine Industry Survey and 2022 Future Outlook

Market Synopsis of Benzodiazepine Market:

Market Scenario:

Benzodiazepines (BZD) are a class of psychoactive drugs with sedative, hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal symptoms.

The prescribing of BZD’s as a whole had diminished greatly since their heyday of the 1970s. After the late 1980s, the initial decline of BZD’s was further hastened by the rise of the Selective Serotonin Reuptake Inhibitors (SSRIs) and the shift of psychiatry from anxiety to depression. However the tide turned in favor of BZD’s by the year 2000.

Between 2005 and 2008, 11% of all Americans over the age of 12 took an anti-anxiety medication. This along with the development of Xanax and the inclusion of anti-anxiety medication in health care programs in the U.S. has led to revival of benzodiazepines. Other factor in favor of BZD’s is the weak pipeline of novel anti-anxiety drugs and sluggish growth of 2.5 % CAGR in general anxiety disorder market.

The BZD are proving themselves as a middle ground as compared to other drugs, which has placed them in favorable positions once again, albeit in a declining market. Unless there is discovery of newer safer alternative drugs the BZD’s are here to stay as they have lesser side effects as compared to barbiturates and the lack of efficacy and late onset of action of Selective Serotonin Reuptake Inhibitor (SSRI’s).

Thus taking all these factors together, we expect the Benzodiazepine market to grow at a CAGR of 1.5% to 2.3% by 2022. The International Narcotics Control Board (INCB) reported that Italy (32 %), India (19 %), China (11 %) and Germany (10 %) were the leading manufacturers between 1997 and 2006.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2281

Segments:

Global Benzodiazepine market has been segmented on the basis of applications (anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal symptoms and as anesthesia supplements. On the basis of time of action the market is segmented into long acting and short acting Benzodiazepines.

 Key Players for Global Benzodiazepine Market:

Some of the key players of this market are AstraZeneca plc, Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and Sanofi S.A.

Intended Audience

  • Benzodiazepine manufacturers
  • Benzodiazepine suppliers
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Government Research Laboratories

Browse Report Details @ https://www.marketresearchfuture.com/reports/benzodiazepine-market

Regional Analysis of Global Benzodiazepine Market:

Globally North America is the largest market for Benzodiazepine. The North American market for Benzodiazepine is expected to reach at USD 2.4 billion by the end of the forecast period of 2016-2022. Europe is the second-largest market for Benzodiazepine. Asia pacific region is expected to be fastest growing region in Benzodiazepine market.

The report for Global Benzodiazepine Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

 

 

 

 

 

 

 

 

 

 

Designed by CyFocus.com
Powered by CyFocus.net